Niksan Pharmaceutical is one of the biggest manufacturer, supplier, exporter and trader of the Amisulpride finished formulations moreover Amisulpride API. Niksan Pharmaceutical is the huge manufacturer, exporter and supplier of Amisulpride API and formulation situated in Ankleshwar, Gujarat, India.
Niksan Pharmaceutical is the suppliers, manufacturer, exporters and trader of
Amisulpride in the domestic level as well as the international market.
Niksan is an Indian based pharmaceutical company so it also supplies and manufactures the Amisulpride to alI Indian states like Gujarat, Maharashtra, Punjab, Delhi, Tamilnadu, Goa, Uttar Pradesh, Karnataka, Jammu & Kashmir, West Bengal, Assam, Rajasthan, Hyderabad,Karnataka, Kerala, Madhya Pradesh, Manipur, Meghalaya, Mizoram, Nagaland,Orissa, Punjab and Haryana.
Niksan Pharmaceutical and Niksan group companies are exporters, suppliers and manufacturers of the API and also Amisulpride formulations in many countries for many years. Niksan pharmaceutical currently exports Amisulpride API and Formulation to countries like New Zealand, Jordan, Belgium, United Kingdom, Australia,Italy, Ireland, Hong Kong, Morocco,, Portugal, France, South Africa,Philippines, Malaysia, Singapore, Israel, Greece, Saudi Arabia, Egypt, Taiwan,Netherlands, South Korea, Switzerland, Algeria, Pakistan, Canada, Vietnam,United States, Germany, Brazil and many other countries.
Amisulpride belongs to the class called ant ipsychotic s. Amisulpride used in the treatment o fschizophrenia and acute psychotic attacks. Amisulpride also used as anti emeticagent at a lower dose.
SYNONYSMS: Aminosultopride, Amisulprida,Amisulpride, Amisulpridum
IUPAC NAME: 4-amino-5-(ethanesulfonyl)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide
CAS NO: 71675-85-9
MOLECULAR MASS: 369 .479 g/mol
STORAGE CONDITIONS: Keep your tablets in the original pack. Keep tablet in cool and dry place do not store Amisulpride in the bathroom or near a sink.
HOW TO USE: Take this medicine orally once a day. Take doses up to 300mg and higher dose should be taken by time intervals. Take this medicine regularly to get maximum effects and result.
HOW AMISULPRIDE WORKS: Amisulpride blocks the presynaptic dopamine receptors and increase the dopamine transmission and by this mechanism Amisulpride gives anti-psychotic effects.
PHARMACOKINETICS OF AMISULPRIDE: Amisulpride absorbed rapidly after the oral administration. The bioavaibility of the Amisulpride is around 48%. Amisulpride binds with only 17%of plasma proteins. The half-life of Amisulpride is approximately 12 hours. Amisulpride excreted by the urination and the elimination half-life of the medicine is 12hours.
SIDE EFFECTS OF AMISULPRIDE: The normal side effects caused by Amisulpride are dry mouth,breast pain, irregular menstrual periods in woman, feeling sleepy/ drowsiness,constipation. Some major side effects of Amisulpride are uncontrollable muscle movement, putting weight, breast enlargement in men, anxiety. Some rare allergic side effects like rash, itching, burning of skin are seen in some patients.
PRECAUTIONS: Tell your doctor if you are allergic to the medicine. Ask your doctors advice if you have medical history like diabetes, heart problem, liver problem, kidney disease, breast cancer or tumor. If you are taking the other medication kindly tell your doctor about it. This medication makes you dizzy so kindly avoid driving or operating the machineries. Donot do any heavy workout after taking the medication. Kindly avoid taking medicine if you are pregnant or in lactation period.
CDSCO APPROVAL: Amisulpride 400mg tablet (additional strength) 01.12.2006
Amisulpride S.R.Bilayered tablet 200/400mg 03.11.2008
Amisulpride 50/100/200 and 400mg Tablets 12.03.2010
FORMULATIONS AVAILABLE IN MARKET:
Amisulpride 50 MG tablets
Amisulpride 25 MG tablets
Amisulpride 100 MG tablets
Amisulpride 200 MG tablets
Amisulpride 400 MG tablets
Amisulpride 300 MG tablets
Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk
Developed and Managed by Infocom Network Private Limited.